00
Days
00
Hours
00
Minutes
00
Seconds
New advances in Immunopharmacology: COVID-19 emergent treatments, Immunobiology of SARS-COV-2and other human pathogenic viruses, cancer and chromic inflammatory diseases, regulation of cancer immune response,acute inflammation and pain, OMICS platforms for drug discovery
Neuroimmunology, neuroimmunopharmacology and neuroimmunomodulation
Hereditary Ataxias and other Neurodegenerative diseases
Pharmacology of cytochrome P450 and transporters
Peptides and Immunopharmacology tools
Advances in Immunology, Vaccines and Therapy of Infectious Diseases
Cellular death
Covid-19 and other Viral Vaccines
Meningococcal and Gonococcal Vaccines
Pneumococcal Vaccines
Enteric Vaccines
Combined Vaccines
Vaccine Technology and Bioprocesses
Implementation of 3Rs methods in QC of vaccines
Technological Transfers
Regulatory issues
The Organizers will publish the full Scientific Program via Website with Keynote Lecturesfrom well-known invited speakers and Oral Presentations chosen from submitted abstracts.
Oral and Poster presentations should be clearly indicated.
The Organizing Committee will have the right of choosing oral presentations.
English is the Congress official language. Translation services will be not available.
The Organizing Committee of IMMUNOPHARMACOLOGY - VACCIPHARMA 2023 will inform authors via E-mailabout the acceptance of abstracts not later than one month after the deadline.
Abstracts Submission Deadline: April 30th, 2023.
Foreign delegates must send their abstracts by E-mail to: Dr. Mario Landys Chovel Cuervo, E-mail: mlandys@finlay.edu.cu and or mlchovel@gmail.com
Cuban abstracts for the Congress IMMUNOPHARMACOLOGY 2023 must be sent by E-mail to: immunopharmacology2023@ cigb.edu.cu
Cuban abstracts for the Congress VACCIPHARMA 2023 must be sent by E-mail to: vaccipharma@finlay.edu.cu
Full Instructions to Write Abstracts: Authors should provide their abstract in Word format (Single space). Title: In Blackand capital letter, Arial 12; Abstract text in Arial 10. Authors: Last name and first letter of the name of each author, using comas among authors (in black, Arial 10). The name of the author who will present the work should be underlined e.g. Rodeiro I, Menendez R, Remirez D. Affiliation: Indicate Institution, Addresses and E-mail of each author below the names and before the abstract text. Abstracts texts should be clear and precise. They should contain a brief introduction, materials and methods used,the results achieved in research and conclusions. 300 words maximum. Abstracts not following the structure above described will beautomatically rejected.
When sending the abstract, please, indicate the Congress (IMMUNOPHARMACOLOGY or VACCIPHARMA), the Workshop / Symposium and the Topic in which you would like to be included. Each author will have the opportunity to send just one abstract to each Congress.
The Congress program will be also printed and distributed on site.
The Organizers will provide a letter of invitation to participants, if requested, to make easier the steps for obtaining visa and funds. This letter does not necessarily imply any financial support from the Congress Organizing Committee.